Results 171 to 180 of about 11,187 (212)
Some of the next articles are maybe not open access.
Recombinant human parvovirus B19 vectors
Pathologie Biologie, 2002In an attempt to exploit the remarkable tissue-tropism of the human parvovirus B19 to target human hematopoietic cells of the erythroid lineage, recombinant human adeno-associated virus 2 genomes were encapsidated in parvovirus B19 capsids. Although efficient transduction of primary human hematopoietic cells in the erythroid lineage occurred, a low ...
Kirsten A, Weigel-Kelley +1 more
openaire +2 more sources
Human parvovirus B19 and rheumatoid arthritis
Clinical Rheumatology, 1992Human parvovirus B19 infections have been linked with the development of a short-lived symmetrical polyarthritis and, rarely, a more persistent arthritis. We prospectively looked for serological evidence of recent B19 infection in 25 early synovitis patients presenting within 12 weeks of symptom onset and compared them with 21 controls seen over the ...
H G, Taylor, A A, Borg, P T, Dawes
openaire +2 more sources
1995
Human parvovirus B19 belongs to the family Parvoviridae and is the only recognised human member of the family. It was first discovered in 1982 when serum specimens were being examined in the electron microscope for the presence of hepatitis B surface antigen.
John Coia, Heather Cubie
openaire +1 more source
Human parvovirus B19 belongs to the family Parvoviridae and is the only recognised human member of the family. It was first discovered in 1982 when serum specimens were being examined in the electron microscope for the presence of hepatitis B surface antigen.
John Coia, Heather Cubie
openaire +1 more source
Human parvovirus (B19) and erythema infectiosum
The Journal of Pediatrics, 1985An outbreak of erythema infectiosum ("fifth disease") was studied in Fukuoka, Japan, in 1980-1981. Human parvovirus (HPV) antigen was not detected in any patients, but anti-HPV, measured by countercurrent immunoelectrophoresis, was found in 33 of 34 affected children and in 21 (15%) of 141 children of the same ages without the disease. Immunoglobulin M
T, Nunoue +3 more
openaire +2 more sources
Update of the human parvovirus B19 biology
Transfusion Clinique et Biologique, 2016Since its discovery, the human parvovirus B19 (B19V) has been associated with many clinical situations in addition to the prototype clinical manifestations, i.e. erythema infectiosum and erythroblastopenia crisis. The clinical significance of the viral B19V DNA persistence in sera after acute infection remains largely unknown.
A, Servant-Delmas, F, Morinet
openaire +2 more sources
Persistence of human parvovirus B19 in human tissues
Pathologie Biologie, 2002Human parvovirus B19 infection causes various clinical symptoms, such as rash, arthropathy, anemias and fetal death, but it can also remain asymptomatic. The arthropathies and anemias can become chronic for several years, not infrequently resembling autoimmune syndromes.
Maria, Söderlund-Venermo +4 more
openaire +2 more sources
Fetal pathology in human parvovirus B19 infection
BJOG: An International Journal of Obstetrics & Gynaecology, 1989Summary. In a current Netherlands study on the effects on mother and child of infection with the human parvovirus B19 during pregnancy, 10 pregnancies have been reported. Three of them ended before term: two in fetal death and one by elective abortion.
A M, Van Elsacker-Niele +5 more
openaire +2 more sources
B19 virus—a pathogenic human parvovirus
Blood Reviews, 1987B19 virus is the first human virus to be shown to be a member of the parvovirus genus. This review is concerned with the diseases associated with B19 virus, their nature, pathogenesis and diagnosis. The virus was discovered by chance in blood donors but has been shown to be a common infection of childhood.
openaire +2 more sources
2014
Human parvavirus B19'un morfolojisi, oluşturduğu enfeksiyonun klinik belirtileri,tanı yöntemleri, epidemik özellikleri göz önüne alındığında, özellikle kronik olgularda B19 antikorlarının ilave edildiği immünglobulinlerin intravenöz infüzyonunun tedavide etkili olabilmektedir.
openaire +1 more source
Human parvavirus B19'un morfolojisi, oluşturduğu enfeksiyonun klinik belirtileri,tanı yöntemleri, epidemik özellikleri göz önüne alındığında, özellikle kronik olgularda B19 antikorlarının ilave edildiği immünglobulinlerin intravenöz infüzyonunun tedavide etkili olabilmektedir.
openaire +1 more source